Education
About Us
Working with TipRanks
Follow Us
Pediatrix Medical Group (MD)
NYSE:MD
MD Analyst Ratings
Moderate Buy
2 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MD Stock 12 Month Forecast
Average Price Target
$21.33
▼(-2.74% Downside)
| Highest Price Target$24.00 | Average Price Target$21.33 | Lowest Price Target$17.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Truist Financial
$17→$24
Buy
9.44%
Upside
Reiterated
11/10/25
TR | OpenAI - 4o
$19→$25
Buy
14.00%
Upside
Reiterated
11/08/25
AI Generated ArticleAI Generated Article
UBS
$16.5→$23
Hold
4.88%
Upside
Reiterated
11/05/25
William Blair
―
Buy
―
Reiterated
11/03/25
Pediatrix Medical Group: Strong Financial Performance and Strategic Improvements Justify Buy RatingWe believe this improvement is primarily due to the recent exit from noncore operations, such as primary and urgent care sites, which was completed at the end of 2024. Higher acuity cases and more favorable reimbursement trends are contributing factors to this quarter's performance, in our view. At the same time, the continued strength in same-store growth reflects ongoing improvements in collection activity, higher patient acuity in neonatology, increased administrative fees, and a more favorable payer mix. Hospital-based patient services and office-based patient services were up about 0.7% and down 0.6%, respectively; neonatal intensive care unit (NICU) days increased by roughly 2.2%. In total, same-unit revenue attributable to patient volume increased 0.4% for the quarter.
Leerink Partners
$17
Hold
-22.48%
Downside
Reiterated
10/03/25
Mizuho Securities
$15→$18
Hold
-17.92%
Downside
Reiterated
02/21/25
Jefferies
$21
Buy
-4.24%
Downside
Reiterated
02/20/25
We commend the strong performance, appreciate the conservative FY25 bar, and would highlight that MD's profile is consistent with a hypothetical PE M&A candidate. Remain bullish & see upside to FY25 despite honoring the guide w/ our new ests. PT to $21, 12.5x FY25 P/E.
Macquarie
$18
Buy
-17.92%
Downside
Reiterated
01/31/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
$17→$24
Buy
9.44%
Upside
Reiterated
11/10/25
TR | OpenAI - 4o
$19→$25
Buy
14.00%
Upside
Reiterated
11/08/25
AI Generated ArticleAI Generated Article
UBS
$16.5→$23
Hold
4.88%
Upside
Reiterated
11/05/25
William Blair
―
Buy
―
Reiterated
11/03/25
Pediatrix Medical Group: Strong Financial Performance and Strategic Improvements Justify Buy RatingWe believe this improvement is primarily due to the recent exit from noncore operations, such as primary and urgent care sites, which was completed at the end of 2024. Higher acuity cases and more favorable reimbursement trends are contributing factors to this quarter's performance, in our view. At the same time, the continued strength in same-store growth reflects ongoing improvements in collection activity, higher patient acuity in neonatology, increased administrative fees, and a more favorable payer mix. Hospital-based patient services and office-based patient services were up about 0.7% and down 0.6%, respectively; neonatal intensive care unit (NICU) days increased by roughly 2.2%. In total, same-unit revenue attributable to patient volume increased 0.4% for the quarter.
Leerink Partners
$17
Hold
-22.48%
Downside
Reiterated
10/03/25
Mizuho Securities
$15→$18
Hold
-17.92%
Downside
Reiterated
02/21/25
Jefferies
$21
Buy
-4.24%
Downside
Reiterated
02/20/25
We commend the strong performance, appreciate the conservative FY25 bar, and would highlight that MD's profile is consistent with a hypothetical PE M&A candidate. Remain bullish & see upside to FY25 despite honoring the guide w/ our new ests. PT to $21, 12.5x FY25 P/E.
Macquarie
$18
Buy
-17.92%
Downside
Reiterated
01/31/25
Best Analysts Covering Pediatrix Medical Group
1 Month
xxx
Success Rate
2/2 ratings generated profit
Average Return
+12.55%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +12.55% per trade.
3 Months
xxx
Success Rate
2/2 ratings generated profit
Average Return
+13.65%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +13.65% per trade.
1 Year
2 Years
xxx
Success Rate
3/3 ratings generated profit
Average Return
+22.37%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +22.37% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MD Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
1
4
4
6
4
Hold
15
13
10
7
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
17
14
13
10
Each month's total comprises the sum of three months' worth of ratings.
MD Financial Forecast
MD Stock Forecast FAQ
What is MD’s average 12-month price target, according to analysts?
Based on analyst ratings, Pediatrix Medical Group’s 12-month average price target is 21.33.
What is MD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MD a Buy, Sell or Hold?
Pediatrix Medical Group has a consensus rating of Moderate Buy which is based on 2 buy ratings, 2 hold ratings and 0 sell ratings.
What is Pediatrix Medical Group’s price target?
The average price target for Pediatrix Medical Group is 21.33. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $24.00 ,the lowest forecast is $17.00. The average price target represents -2.74% Decrease from the current price of $21.93.
The highest analyst price target is $24.00 ,the lowest forecast is $17.00. The average price target represents -2.74% Decrease from the current price of $21.93.
What do analysts say about Pediatrix Medical Group?
Pediatrix Medical Group’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of MD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.